Concepedia

Niko Schmiedeberg

NS

10

Publications

517

Citations

10

H-Index

2000

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Technical University of Munich

Klinikum rechts der Isar

Wilex (Germany)

Niko Schmiedeberg is an author at Novartis (Switzerland) specializing in medicine, natural sciences, and molecular biology.

Top concepts

Publications per year

2000–2024

10

Publications

10

The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis

Georg Martiny‐Baron, Philipp Holzer, Éric Billy et al. · Angiogenesis · 2010 · 124 citations · Full text

G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype

Klemens Högenauer, Luca Arista, Niko Schmiedeberg et al. · Journal of Medicinal Chemistry · 2014 · 92 citations

, , +26

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 71 citations · Full text

Reversible Backbone Protection Enables Combinatorial Solid-Phase Ring-Closing Metathesis Reaction (RCM) in Peptides

Niko Schmiedeberg, Horst Kessler · Organic Letters · 2001 · 53 citations

, , +12

Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics

Niko Schmiedeberg, Manfred Schmitt, Christian Rölz et al. · Journal of Medicinal Chemistry · 2002 · 42 citations · Full text

Rows per page

1–5 of 10